OrbiMed Genesis GP LLC, 10% Owner at PMV Pharmaceuticals, Inc. (PMVP), sold 509,000 shares at $21.17 ($11.0M) on 2022-03-31, disclosed to the SEC on 2022-03-31.
Open-market sale of $11.0M PMVP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.52 | 365,000 | $7.9M | 71.4% |
| 2 | $22.39 | 75,000 | $1.7M | 15.3% |
| 3 | $21.17 | 34,500 | $730K | 6.6% |
| 4 | $21.17 | 34,500 | $730K | 6.6% |
| Total | $21.60 avg | 509,000 | $11.0M | 100% |
| Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| KROS | SELL | 2024-08-15 | $11.0M | — | Filing → |
| TERN | SELL | 2024-07-17 | $562K | — | Filing → |